313271-23-7 Usage
Class of compounds
Thiazolidinediones
Derivative
Contains a 5-(2-propenyl) group
Therapeutic potential
Used for treating diabetes
Mechanism of action
Improves insulin sensitivity and decreases blood glucose levels
Specific biological activities
Potentially imparted by the 5-(2-propenyl) substitution, but further research is needed
Interest to researchers and pharmaceutical companies
Potential use in the development of new treatments for diabetes and related metabolic disorders
Check Digit Verification of cas no
The CAS Registry Mumber 313271-23-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,1,3,2,7 and 1 respectively; the second part has 2 digits, 2 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 313271-23:
(8*3)+(7*1)+(6*3)+(5*2)+(4*7)+(3*1)+(2*2)+(1*3)=97
97 % 10 = 7
So 313271-23-7 is a valid CAS Registry Number.
313271-23-7Relevant articles and documents
Solution- and solid-phase synthesis of peptide-substituted thiazolidinediones as potential PPAR ligands
Mohler, Debra L.,Shen, Gang,Dotse, Anthony K.
, p. 2239 - 2242 (2000)
Solution- and solid-phase methods for the preparation of peptide-substituted thiazolidinediones have been developed as an approach towards the preparation of a library of these compounds as potential ligands for the peroxisome proliferator-activated receptors (PPARs). (C) 2000 Elsevier Science Ltd.
